<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11859925</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1572</article-id><article-id pub-id-type="other">EPV0985</article-id><article-id pub-id-type="pii">S0924933824015724</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Cognitive impairment assessment in schizophrenia. purposely a case</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Ogando Portilla</surname><given-names>N.</given-names></name><xref rid="aff3413" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1421" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ba&#x000f1;&#x000f3;n Gonz&#x000e1;lez</surname><given-names>S. M.</given-names></name><xref rid="aff3413" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gamo Bravo</surname><given-names>B.</given-names></name><xref rid="aff3413" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gonz&#x000e1;lez Laynez</surname><given-names>M. E.</given-names></name><xref rid="aff3414" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Urbanos</surname><given-names>M. A.</given-names></name><xref rid="aff3415" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cort&#x000e9;s</surname><given-names>M. M.</given-names></name><xref rid="aff3416" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="aff3413"><sup>1</sup>Psychiatry, <institution>Hospital Universitario Infanta Sof&#x000ed;a</institution>, <city>Madrid</city></aff><aff id="aff3414"><sup>2</sup>Psychiatry, <institution>Hospital universitario de Toledo</institution>, <city>Toledo</city></aff><aff id="aff3415"><sup>3</sup>Psychiatry, <institution>Hospital Universitario La Princesa</institution>, <city>Madrid</city></aff><aff id="aff3416"><sup>4</sup>Psychiatry, <institution>Hospital General Universitario de Alicante Dr Balmis</institution>, <city>Alicante</city>, <country>Spain</country></aff><author-notes><corresp id="cor1421"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1547">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S755</fpage><lpage>S755</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824015724a.pdf"/><abstract><sec id="sec8542"><title>Introduction</title><p>
Significant and measurable&#x000a0;cognitive symptoms are present at the onset of the disorder and these remain stable in the subsequent period between 2 and 5 years. Their deterioration increases with the course of the disease.&#x000a0;Attention, concentration, psychomotor speed and resolution of conceptual tasks are usually affected and are more significant in the presence of positive symptoms.</p></sec><sec id="sec8543"><title>Objectives</title><p>
Sometimes, the typical positive or negative symptoms of the disease do not adequately reflect the severity of cognitive impairment. Measuring this deterioration can be very relevant when evaluating the severity and the prognosis of the disorder.</p></sec><sec id="sec8544"><title>Methods</title><p>31-year-old male with a previous diagnosis of schizophrenia of 4 years of evolution. He gets a maintained treatment with amisulpiride 400mg with an apparent good response. A single hospitalization at the onset of the disease.&#x000a0;An assassination attempt on his mother is done by suffocation with a pillow and observing a significant cognitive&#x000a0;impairment&#x000a0;despite an apparent control of the symptoms of schizophrenia.</p></sec><sec id="sec8545"><title>Results</title><p>An exhaustive neuropsychological evaluation is carried out, observing a very important cognitive deterioration that had not been previously detected and allowing a pharmacological adjustment of the underlying disease with global improvement of the patient.</p></sec><sec id="sec8546"><title>Conclusions</title><p>It is very important to evaluate the patient as a whole without forgetting the frequent cognitive damage that these patients can have. An intense neuropsychological study can be very useful to evaluate the prognosis and adequate treatment of the patient in order to reduce serious risks.</p></sec><sec id="sec8547"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>